Achieving Universal, Fully Fault-Tolerant Quantum Computing: A Necessity for BioTech Innovation

Achieving Universal, Fully Fault-Tolerant Quantum Computing: A Necessity for BioTech Innovation

Thursday, October 10, 2024 12:45 PM to 1:05 PM · 20 min. (Europe/Brussels)
Quantum Pharma
Presentation
Theatre 8
Quantinuum

Registered attendees

Alasdair Thomson
Alasdair Thomson
Principal Product OwnerNovo Nordisk
DVH
Dirk Van Hyfte
Head of InnovationIPA Therapeutics
Franziska Wolff
Franziska Wolff
Lead Quantum ScientistCapgemini

Log in